0->Determine the semantic entailment between individual sections of Clinical Trial Reports (CTRs) and expert-issued statements, focusing on methodology, outcomes, efficacy, and safety of new treatments. Analyze the ELIGIBILITY CRITERIA, INTERVENTION details, RESULTS, and ADVERSE EVENTS sections of CTRs. Ensure that expert statements align with, support, and do not contradict the information within these sections for a single CTR or in comparative analyses between two CTRs.
----------
1->Your task is determining support relationships between individual sections of Clinical Trial Reports (CTRs) and clinical statements. CTRs detail the methodology and findings of clinical trials, assessing effectiveness and safety of new treatments. CTRs consist of 4 sections: (1) ELIGIBILITY CRITERIA listing conditions for patient participation, (2) INTERVENTION description specifying type, dosage, frequency, and duration of treatments, (3) RESULTS summary detailing participants, outcome measures, units, and conclusions, and (4) ADVERSE EVENTS listing signs and symptoms observed. Statements make claims about information in these sections, either for a single CTR or comparing two.
----------
2->Determine the semantic entailment between individual sections of Clinical Trial Reports (CTRs) and expert-issued statements, focusing on methodology, outcomes, efficacy, and safety of new treatments. Analyze the ELIGIBILITY CRITERIA, INTERVENTION details, RESULTS, and ADVERSE EVENTS sections of CTRs. Ensure that expert statements align with, support, and do not contradict the information within these sections for a single CTR or in comparative analyses between two CTRs.
----------
3->

Evaluate the semantic correspondence between segments of Clinical Trial Reports (CTRs) and authoritative assertions concerning clinical trials' methodologies, results, efficacy, and safety. Scrutinize authoritative assertions for congruence with CTR segments: (1) ELIGIBILITY CRITERIA, which delineates the conditions for patient inclusion, (2) INTERVENTION, detailing the intervention type, dosage, administration frequency, and trial length, (3) RESULTS, specifying participant demographics, outcome metrics, units of measurement, and findings, and ( 4) ADVERSE EVENTS, noting any observed adverse signs and symptoms. Confirm that authoritative assertions are substantiated by CTR segments, find corroboration within the CTR, and refrain from contradicting the descriptions.
----------
4->

Evaluate the correlation between distinct components of Clinical Trial Reports (CTRs) and clinical assertions pertaining to trial methodology, results, efficacy, and safety. Scrutinize statements for alignment with CTR segments: (1) ELIGIBILITY CRITERIA, which encompasses the conditions for patient inclusion, (2) INTERVENTION, detailing the intervention type, dosage, administration frequency, and trial length, (3) RESULTS, describing participant demographics, outcome metrics, units of measurement, and findings, and (4) ADVERSE EVENTS, noting any observed adverse signs and symptoms. Confirm that statements are in harmony with CTR data, are corroborated within the CTR, and do not conflict with CTR descriptions.
----------
